Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-01

Clinical Trial Update: A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium [Phase 2]

View source ↗

Summary

Phase 2 trial of nitazoxanide in patients with AIDS and Cryptosporidium-induced diarrhea (cryptosporidiosis) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitazoxanide (nitazoxanide)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Cryptosporidiosis, HIV Infections | Phase 2 | Status: COMPLETED